186 related articles for article (PubMed ID: 17404615)
1. Yin and yang interplay of IFN-gamma in inflammation and autoimmune disease.
Zhang J
J Clin Invest; 2007 Apr; 117(4):871-3. PubMed ID: 17404615
[TBL] [Abstract][Full Text] [Related]
2. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.
Guillonneau C; Hill M; Hubert FX; Chiffoleau E; Hervé C; Li XL; Heslan M; Usal C; Tesson L; Ménoret S; Saoudi A; Le Mauff B; Josien R; Cuturi MC; Anegon I
J Clin Invest; 2007 Apr; 117(4):1096-106. PubMed ID: 17404623
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical roles of interferon-gamma in autoimmune disease.
Zhang J
Expert Rev Clin Immunol; 2007 Jan; 3(1):35-8. PubMed ID: 20476949
[TBL] [Abstract][Full Text] [Related]
4. How interferon-gamma keeps autoimmune diseases in check.
Kelchtermans H; Billiau A; Matthys P
Trends Immunol; 2008 Oct; 29(10):479-86. PubMed ID: 18775671
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.
Konieczny BT; Dai Z; Elwood ET; Saleem S; Linsley PS; Baddoura FK; Larsen CP; Pearson TC; Lakkis FG
J Immunol; 1998 Mar; 160(5):2059-64. PubMed ID: 9498741
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
7. Routes to allograft survival.
Bromberg JS; Murphy B
J Clin Invest; 2001 Apr; 107(7):797-8. PubMed ID: 11285297
[No Abstract] [Full Text] [Related]
8. Regulatory T cell enrichment by IFN-γ conditioning.
Feng G; Wood KJ; Bushell A
Methods Mol Biol; 2011; 677():281-301. PubMed ID: 20941618
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ is reciprocally involved in the concurrent development of organ-specific autoimmunity in the liver and stomach.
Iwamoto S; Kido M; Aoki N; Nishiura H; Maruoka R; Ikeda A; Okazaki T; Chiba T; Watanabe N
Autoimmunity; 2012 Mar; 45(2):186-98. PubMed ID: 21995497
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
[TBL] [Abstract][Full Text] [Related]
11. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
12. The yin and yang of B cells in graft rejection and tolerance.
Zarkhin V; Chalasani G; Sarwal MM
Transplant Rev (Orlando); 2010 Apr; 24(2):67-78. PubMed ID: 20149626
[TBL] [Abstract][Full Text] [Related]
13. Local T cell responses induce widespread MHC expression. Evidence that IFN-gamma induces its own expression in remote sites.
Halloran PF; Autenried P; Ramassar V; Urmson J; Cockfield S
J Immunol; 1992 Jun; 148(12):3837-46. PubMed ID: 1602132
[TBL] [Abstract][Full Text] [Related]
14. Wild-type but not interferon-gamma-deficient T cells induce graft arterial disease in the absence of B cells.
Furukawa Y; Cole SE; Shah RV; Fukumoto Y; Libby P; Mitchell RN
Cardiovasc Res; 2004 Aug; 63(2):347-56. PubMed ID: 15249193
[TBL] [Abstract][Full Text] [Related]
15. The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis.
Matthys P; Vermeire K; Heremans H; Billiau A
J Leukoc Biol; 2000 Oct; 68(4):447-54. PubMed ID: 11037964
[TBL] [Abstract][Full Text] [Related]
16. [Interferon-gamma, the Th1/Th2 paradigm and autoimmune diseases].
Billiau A
Verh K Acad Geneeskd Belg; 1998; 60(4):271-85. PubMed ID: 9883078
[TBL] [Abstract][Full Text] [Related]
17. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
Takayanagi H; Ogasawara K; Hida S; Chiba T; Murata S; Sato K; Takaoka A; Yokochi T; Oda H; Tanaka K; Nakamura K; Taniguchi T
Nature; 2000 Nov; 408(6812):600-5. PubMed ID: 11117749
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine.
Nakagome K; Okunishi K; Imamura M; Harada H; Matsumoto T; Tanaka R; Miyazaki J; Yamamoto K; Dohi M
J Immunol; 2009 Jul; 183(1):209-20. PubMed ID: 19542432
[TBL] [Abstract][Full Text] [Related]
19. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
